COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
77 EUR
-3.48 (-4.32%)
We assign a fundamental rating of 5 out of 10 to CBHD. CBHD was compared to 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
CBHD had positive earnings in each of the past 5 years.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CBHD (7.52%) is better than 81.67% of its industry peers.
CBHD has a Return On Equity of 22.55%. This is amongst the best in the industry. CBHD outperforms 91.67% of its industry peers.
With an excellent Return On Invested Capital value of 12.65%, CBHD belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CBHD is above the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD's Profit Margin of 13.04% is fine compared to the rest of the industry. CBHD outperforms 78.33% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD has a better Operating Margin (27.52%) than 96.67% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
Looking at the Gross Margin, with a value of 67.97%, CBHD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
Compared to 5 years ago, CBHD has more shares outstanding
Compared to 1 year ago, CBHD has an improved debt to assets ratio.
2.2 Solvency
CBHD has an Altman-Z score of 3.96. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD has a better Altman-Z score (3.96) than 71.67% of its industry peers.
The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.34, CBHD perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.24, CBHD is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.96 |
ROIC/WACC2.2
WACC5.76%
2.3 Liquidity
CBHD has a Current Ratio of 1.61. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.61, CBHD perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a worse Quick ratio (1.00) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.34%.
Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.08% on average per year.
CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%1.74%
3.2 Future
The Earnings Per Share is expected to grow by 23.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.53% on average over the next years.
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 42.31, the valuation of CBHD can be described as expensive.
CBHD's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.56, CBHD is valued quite expensively.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 22.22.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBHD is on the same level as its industry peers.
CBHD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.62, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.31 | ||
| Fwd PE | 22.22 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBHD.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 71.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.17 | ||
| EV/EBITDA | 15.63 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBHD may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 35.02% in the coming years.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y45.02%
EPS Next 3Y35.02%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.82%, CBHD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.11, CBHD pays a better dividend. On top of this CBHD pays more dividend than 98.33% of the companies listed in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
FRA:CBHD (11/17/2025, 7:00:00 PM)
77
-3.48 (-4.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.19B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts68.46
Price Target92.01 (19.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.58%
Min EPS beat(2)-92.81%
Max EPS beat(2)-22.36%
EPS beat(4)0
Avg EPS beat(4)-36.47%
Min EPS beat(4)-92.81%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-20.36%
EPS beat(12)0
Avg EPS beat(12)-16.18%
EPS beat(16)1
Avg EPS beat(16)-13.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.17%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)4
Avg Revenue beat(16)-0.85%
PT rev (1m)-2.64%
PT rev (3m)-8.24%
EPS NQ rev (1m)9.43%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-10.56%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-2.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.31 | ||
| Fwd PE | 22.22 | ||
| P/S | 4.34 | ||
| P/FCF | 23.17 | ||
| P/OCF | 18.19 | ||
| P/B | 7.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.63 |
EPS(TTM)1.82
EY2.36%
EPS(NY)3.46
Fwd EY4.5%
FCF(TTM)3.32
FCFY4.32%
OCF(TTM)4.23
OCFY5.5%
SpS17.76
BVpS10.27
TBVpS-8.72
PEG (NY)0.47
PEG (5Y)N/A
Graham Number20.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.96 |
F-Score6
WACC5.76%
ROIC/WACC2.2
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%1.74%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year28.29%
EBIT Next 3Y15.9%
EBIT Next 5Y12.37%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 89.92% in the next year.